(PDF) Valganciclovir Use Among Commercially and

Valganciclovir Use Among Commercially and Medicaid-Insured Infants With Congenital CMV Infection in the United States, 2009–2015

Clinical Therapeutics - United States

doi 10.1016/j.clinthera.2018.01.006

Full Text

Open PDF

Abstract

Available in full text

Date

March 1, 2018

Authors

Publisher

Elsevier BV

Related search

Antipsychotic Medication Use Among Publicly Insured Pregnant Women in the United States

English

Uptake of TBO-Filgrastim in the Outpatient Setting Among Commercially Insured and Medicare Supplemental Populations in the United States

English

The Relative Cost of Medicaid Enrollees and the Commercially Insured in HMOs

English

Coccidioidomycosis Skin Testing in a Commercially Insured Population, United States, 2014–20171

Emerging Infectious Diseases

English

Congenital Cytomegalovirus-Related Hospitalizations in Infants <1 Year of Age, United States, 1997–2009

Pediatric Infectious Disease Journal

English

Pin104 - Meningococcal Group B (Menb) Vaccine Series Completion and Compliance Among Commercially-Insured Individuals Aged 16-23 in the United States

English

Hospitalization Costs Related to Pulmonary Hypertension (Ph) Among Medicare Advantage or Commercially Insured Patients With Pulmonary Arterial Hypertension (Pah) in the United States

English

Cytomegalovirus (CMV) Urinary Excretion and Long-Term Outcome in Children With Congenital CMV Infection

English

S03.1: Congenital CMV Infection and Neurologic Morbidity

American Journal of Reproductive Immunology

Gynecology

Reproductive Medicine

English

Amanote Research

Valganciclovir Use Among Commercially and Medicaid-Insured Infants With Congenital CMV Infection in the United States, 2009–2015

Clinical Therapeutics - United States

doi 10.1016/j.clinthera.2018.01.006

Full Text

Abstract

Categories

Date

Authors

Publisher

Related search

Antipsychotic Medication Use Among Publicly Insured Pregnant Women in the United States

Uptake of TBO-Filgrastim in the Outpatient Setting Among Commercially Insured and Medicare Supplemental Populations in the United States

The Relative Cost of Medicaid Enrollees and the Commercially Insured in HMOs

Coccidioidomycosis Skin Testing in a Commercially Insured Population, United States, 2014–20171

Congenital Cytomegalovirus-Related Hospitalizations in Infants <1 Year of Age, United States, 1997–2009

Pin104 - Meningococcal Group B (Menb) Vaccine Series Completion and Compliance Among Commercially-Insured Individuals Aged 16-23 in the United States

Hospitalization Costs Related to Pulmonary Hypertension (Ph) Among Medicare Advantage or Commercially Insured Patients With Pulmonary Arterial Hypertension (Pah) in the United States

Cytomegalovirus (CMV) Urinary Excretion and Long-Term Outcome in Children With Congenital CMV Infection

S03.1: Congenital CMV Infection and Neurologic Morbidity